Exploring the Use of State Medical Cannabis Legislation as a Proxy for Medical Cannabis Use Among Patients Receiving Chemotherapy

Opinion statement The use of medical cannabis is expanding in the USA. Due to conflicting, low-quality evidence, many oncologists may not feel confident to recommend it to patients. Given the potential for legal and financial risks when conducting clinical trials with medical cannabis, the use of ob...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current treatment options in oncology Jg. 22; H. 1; S. 1
Hauptverfasser:	Gressler, Laura E., Baltz, Alan P., Costantino, Ryan C., Slejko, Julia F., Onukwugha, Eberechukwu
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Springer US 01.01.2021 Springer Nature B.V
Schlagworte:	Antiemetics Antiemetics - administration & dosage Antiemetics - adverse effects Antiemetics - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cannabis Chemotherapy Clinical trials Evidence-Based Practice Humans Legislation Legislation, Drug Medical marijuana Medical Marijuana - administration & dosage Medical Marijuana - adverse effects Medical Marijuana - therapeutic use Medical Oncology - methods Medicine Medicine & Public Health Nausea Nausea - drug therapy Nausea - etiology Neoplasms - complications Neoplasms - drug therapy Oncology Palliative and Supportive Care (MP Davis Patients Section Editor Topical Collection on Palliative and Supportive Care Vomiting Vomiting - drug therapy Vomiting - etiology Medical cannabis legislation Prescription use Antiemetic Medical cannabis Chemotherapy-induced nausea and vomiting
ISSN:	1527-2729, 1534-6277, 1534-6277
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!